c-Myc tag Peptide: Atomic Utility in Immunoassays & Cancer Biology

Executive Summary: The c-Myc tag Peptide (SKU: A6003, APExBIO) is a synthetic peptide corresponding to the C-terminal region (amino acids 410–419) of human c-Myc, widely recognized for its role in displacing c-Myc-tagged fusion proteins from anti-c-Myc antibodies in immunoassays (APExBIO product page). c-Myc is a proto-oncogene encoding a transcription factor central to cell proliferation, apoptosis, and differentiation, with dysregulation observed in numerous cancers (Wu et al., 2021). This peptide is highly soluble in DMSO (≥60.17 mg/mL) and water with ultrasonic treatment (≥15.7 mg/mL), but insoluble in ethanol. It provides a benchmark tool for quantitative immunoassays and functional genomics, with strict recommendations for storage and handling to maximize stability (APExBIO). The product is intended solely for research use and is not suitable for diagnostic or medical applications.

Biological Rationale

The c-Myc protein is a member of the basic helix-loop-helix leucine zipper (bHLH-LZ) family of transcription factors, essential for regulating gene expression linked to cell cycle progression, apoptosis, and cellular metabolism (Wu et al., 2021). The C-terminal region of c-Myc, comprising amino acids 410–419, forms the epitope recognized by several anti-c-Myc antibodies, including the widely used 9E10 clone (APExBIO). Tagging proteins with this epitope enables their detection and purification in molecular biology workflows. Due to c-Myc's role as a proto-oncogene, precise tools for modulating and detecting its interactions are critical in cancer research and cell signaling studies. Synthetic c-Myc peptides, such as this product, allow for controlled displacement of fusion proteins from antibody complexes, facilitating downstream analyses and improving assay specificity.

Mechanism of Action of c-Myc tag Peptide

The c-Myc tag Peptide functions as a competitive inhibitor of anti-c-Myc antibody binding. When introduced into immunoassays, it binds to the antigen recognition site of the antibody, displacing c-Myc-tagged fusion proteins or other targets. This displacement is quantitative and enables elution or detection of target proteins without harsh conditions. The peptide's primary sequence (EQKLISEEDL) mimics the natural c-Myc epitope, ensuring high specificity and minimal off-target binding (related content). Mechanistically, this approach allows direct study of protein–protein and protein–antibody interactions central to transcription factor regulation and proto-oncogene research.

Evidence & Benchmarks

• The c-Myc tag Peptide displaces c-Myc-tagged fusion proteins from anti-c-Myc antibodies in immunoprecipitation assays at concentrations ≥1 μg/mL in PBS (pH 7.4) within 30 minutes at room temperature (APExBIO).
• High solubility benchmarks: soluble at ≥60.17 mg/mL in DMSO and ≥15.7 mg/mL in water with ultrasonic treatment; insoluble in ethanol (APExBIO).
• c-Myc activation upregulates cyclins and ribosomal proteins, while repressing p21 and Bcl-2, driving oncogenic transformation in multiple cell types (Wu et al., 2021).
• c-Myc tag Peptide enables antibody inhibition assays with minimal cross-reactivity, as validated by quantitative ELISA and immunoprecipitation controls (see detailed discussion).
• Recommended storage: desiccated at –20°C; solutions are stable for short-term use only (APExBIO).

Applications, Limits & Misconceptions

The c-Myc tag Peptide is primarily used in:

• Displacement of c-Myc-tagged fusion proteins from antibody complexes in immunoassays and immunoprecipitation (APExBIO).
• Quantitative inhibition studies to characterize anti-c-Myc antibody specificity and affinity.
• Probing transcription factor regulation and studying gene amplification in cancer biology (see contrast: this article expands on mechanistic applications beyond baseline protocols).
• Functional genomics workflows requiring precise control of tag–antibody interactions (in contrast: here, we detail quantitative benchmarks and storage parameters).

Common Pitfalls or Misconceptions

• The peptide is NOT suitable for diagnostic or therapeutic use; it is intended for research applications only (APExBIO).
• It does NOT function as a universal competitor for all anti-c-Myc antibodies; sequence specificity matters.
• Long-term storage of peptide solutions leads to degradation; always prepare fresh aliquots for experimental use.
• The c-Myc tag Peptide does NOT directly interfere with endogenous c-Myc function in living cells unless delivered at high, non-physiological concentrations.
• It is NOT a replacement for genetic tagging or knock-in models when studying endogenous gene regulation.

Workflow Integration & Parameters

To integrate the c-Myc tag Peptide into immunoassays:

1. Dissolve the peptide in DMSO (≥60.17 mg/mL) or water with ultrasonic treatment (≥15.7 mg/mL), avoiding ethanol due to insolubility.
2. Prepare fresh working solutions immediately before use.
3. For immunoprecipitation, add peptide to the antibody–protein complex and incubate at room temperature for 30 minutes.
4. Elute displaced c-Myc-tagged protein and analyze by SDS-PAGE or mass spectrometry as required.
5. Store lyophilized peptide desiccated at –20°C; avoid repeated freeze–thaw cycles.

Refer to the A6003 kit product page for detailed protocol recommendations.

Conclusion & Outlook

The c-Myc tag Peptide from APExBIO is a rigorously benchmarked reagent for research applications in immunoassays, transcription factor regulation, and cancer biology. Its atomic design, high solubility, and proven specificity enable precise manipulation of c-Myc–antibody interactions. Continued integration with advanced genomics and proteomics workflows will expand its application in dissecting proto-oncogene function and cellular signaling networks. For further mechanistic insights and quantitative protocols, readers are encouraged to consult both primary literature (Wu et al., 2021) and recent expert analyses (see in-depth mechanistic review).